Search results :

Niacin

More information: STITCH, PubChem and possibly Wikipedia

ATC Codes: C04AC01, C10AD02

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8 9 10 11
Diarrhoea 10% - 14% 13% x x x x x x x x x x x
Nausea 4% - 11% 7% x x x x x x x x x x
Rash 0% - 5% 1% x x x x x x x x x x
Vomiting 2% - 9% 4% x x x x x x x x x x x
Cough 2% - 8% 6% x x x x x x
Anaphylactic shock postmarketing x x x x x x x
Angioedema postmarketing x x x x x x x
Arrhythmia postmarketing x x x x x x x x x x x
Asthenia postmarketing 3% x x x x x x x x
Atrial fibrillation postmarketing x x x x x x x x x x x
Dizziness postmarketing x x x x x x x x
Dyspnoea postmarketing x x x x x x x x
Eructation postmarketing 1% x x x x x x x
Flatulence postmarketing x x x x x x x x
Flushing postmarketing, 55% - 69% x x x x x x x x x x
Gout postmarketing x x x x x x x x x
Hepatitis postmarketing x x x x x
Hypersensitivity postmarketing x x x x x x x
Hypotension postmarketing x x x x x x x x x x x
Orthostatic hypotension postmarketing x x x x x
Jaundice postmarketing x x x x x x x x x x
Laryngeal oedema postmarketing x x x x x x x
Laryngospasm postmarketing x x x x x x x
Myopathy postmarketing x x x x x x
Nervousness postmarketing x x x x x x x x
Palpitations postmarketing 1% x x x x x x x x
Paraesthesia postmarketing x x x x x x x
Peptic ulcer postmarketing x x x x x x x x x x
Sweating postmarketing 1% x x x x x x x x
Syncope postmarketing x x x x x x x x
Tachycardia postmarketing 0% x x x x x x x x
Urticaria postmarketing 1% x x x x x x x x x
Burning sensation postmarketing x x x x x
Oedema peripheral postmarketing x x x x x x x
Migraine postmarketing 1% x x x x x x x
Tongue oedema postmarketing x x x x x x x
Glucose tolerance decreased postmarketing x x x x x x x x x
Vesiculobullous rash postmarketing x x x x x x x
Skin discolouration postmarketing 1% x x x x x x
Dry skin postmarketing x x x x x x x x x x
Myalgia postmarketing x x x x x x x x
Skin burning sensation postmarketing x x x x x
Macular oedema postmarketing x x x x x
Vision blurred postmarketing x x x x x
Rash maculo-papular postmarketing x x x x x x x x
Face oedema postmarketing x x x x x x x
Insomnia postmarketing x x x x x x x x
Abdominal pain x
Acanthosis nigricans x x x x
Alopecia x
Amblyopia x x x x x
Angina pectoris x
Anorexia x
Arthralgia 0% x
Arthritis 2% x
Ascites x
Bone disorder x
Bronchitis x
Bursitis x
Cholelithiasis x
Cholestasis x
Dysphagia x
Dermatitis contact x
Fungal skin infection x
Diabetes mellitus x x x x
Dyspepsia 12% x x x x
Eczema x
Oedema 0% - 1% x x x x x x x x
Oesophagitis x
Eye disorder x
Faecal incontinence x
Body temperature increased 3% x
Fibrosis x
Furunculosis x
Gastrointestinal disorder x x x x x
Gastrointestinal haemorrhage x
Glaucoma x
Headache x x x x x
Heartburn x
Haemoptysis x
Haemorrhage x
Hepatomegaly x
Hernia x
Herpes zoster x
Hyperbilirubinaemia x
Hyperinsulinism x
Hyperventilation x
Hypoaesthesia x
Hypothyroidism x
Libido increased x
Influenza 5% x
Jaundice cholestatic x
Keratosis x
Laryngitis x
Cramps of lower extremities x x
Leukopenia x
Lung disorder x
Cystoid macular oedema x x x x
Breast pain x
Hypertonia x
Necrosis x
Pain 2% - 7% x x x
Polyuria x
Prostatic disorder x
Pruritus 0% - 3% 2% x x x x x x x x x x x
Rhabdomyolysis x x x x x
Rhinitis 31% x x x
Shock x
Neoplasm skin x
Skin ulcer x
Stomatitis x
Tinnitus 1% x
Tongue disorder x
Vaginal inflammation x
Angiopathy x x x x x
Vertigo x
Dry mouth 0% x
Urinary retention x
Chills 1% x x x x x x x x
Hypokinesia x
Hepatic function abnormal x x
Application site reaction x
Generalised oedema x
High density lipoprotein decreased x x x x
Liver function test abnormal x
Mucous membrane disorder x
Malnutrition x
Skin hyperpigmentation x x x x
Unspecified disorder of skin and subcutaneous tissue x x x x
Muscle twitching x
Sensation of heat x
Hepatotoxicity x
Skin exfoliation x
Erectile dysfunction x
Xanthoma x
Redness x x x x x x x x
Enlargement abdomen x
Warmth x x x x x x x x
Gastrointestinal symptom NOS x
Metabolic syndrome x x x x
Sensation of warmth x
Cough increased x x x x x
Blood glucose increased x x x x
Hyperuricaemia x x
Generalized flushing x
Hyperkeratosis x
Raised liver function tests x
Myasthenia x x
Atherothrombosis x x x x
Tingling sensation x x x x x x x x x
Somnolence 1% x
Abnormal vision x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

Nicotinic acid BP. Structural formula: / Nicotinic Acid

Side effects:30
Source:medicines.org.au

niacin

Side effects:20
Source:FDA Structured Product Label

niacin extended-release / Niaspan

Side effects:40
Source:FDA

NIACIN

Side effects:57
Source:FDA Structured Product Label

NIACIN

Side effects:61
Source:FDA Structured Product Label

NIACIN

Side effects:63
Source:FDA Structured Product Label

NIACIN

Side effects:63
Source:FDA Structured Product Label

NIACIN

Side effects:63
Source:FDA Structured Product Label

NICOTINIC ACID / NIASPAN 500MG

Side effects:114
Source:Health Canada

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label